2 ms·
If you actually know the target loci for whatever disease, it's a much more sensible prospect to just put the patient on a drug for life that inhibits whatever
by asdff 6y ago
If you actually know the target loci for whatever disease, it's a much more sensible prospect to just put the patient on a drug for life that inhibits whatever that mutation does. If the treatment turns out unsafe, you just take the patient off. With editing the genome you can't really go back if you find out after the fact that you screwed up. CRISPR is a great research tool, but I think in vitro fertilization is fine enough for catching congenital diseases.
- ImaCake 6y agoThis is a good point, it can be hard to predict what gene does what. Most genes that have been targetted for gene therapies tend to be the singular and known source of a genetic disease. Something like the sodium transporter mutation in cystic fibrosis. If you fix it, it is clear what will happen; you will clear out the disease. Most diseases are not so simple and we are still getting to grips with even mapping the mutations scattered across the genome and the global human population that are relevant to certain diseases. I think when you dont have a single genetic cause, but a mix of various genetic factors instead, then the drug route is optimal. For exactly the reasons you stated.
- Nasrudith 6y agoIn vitro fertilization isn't anywhere close to ubiquitous let alone screening. Genetic editing isn't cheap either but it is only needed for patients with problems instead of literally everybody born. Technically the issue may or may not be drug "additive" and inhibitable like "stop making this protein" but "start making this with your blood cells".